Terms: = Breast cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
19 results:
1. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers.
Chen YC; Chen JH; Tsai CF; Wu CT; Chang PC; Yeh WL
Toxicol Appl Pharmacol; 2024 Feb; 483():116818. PubMed ID: 38215994
[TBL] [Abstract] [Full Text] [Related]
3. M
Liu X; Li P; Huang Y; Li H; Liu X; Du Y; Lin X; Chen D; Liu H; Zhou Y
Redox Biol; 2024 Feb; 69():102993. PubMed ID: 38104484
[TBL] [Abstract] [Full Text] [Related]
4. foxo1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation.
Tang L; Wei D; Xu X; Mo D; Cheng D; Yan F
Breast Cancer Res Treat; 2023 Nov; 202(2):397-408. PubMed ID: 37640964
[TBL] [Abstract] [Full Text] [Related]
5. foxo1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
[TBL] [Abstract] [Full Text] [Related]
6. The foxo1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
Flores D; Lopez A; Udawant S; Gunn B; Keniry M
FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
[TBL] [Abstract] [Full Text] [Related]
7. ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling.
Hwang HJ; Lee KH; Cho JY
Cancer Sci; 2023 Apr; 114(4):1451-1463. PubMed ID: 36576228
[TBL] [Abstract] [Full Text] [Related]
8. The Pan-cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract] [Full Text] [Related]
9. Downregulated Copper Homeostasis-Related Gene foxo1 as a Novel Indicator for the prognosis and Immune Response of breast cancer.
Zeng R; Peng B; Peng E
J Immunol Res; 2022; 2022():9140461. PubMed ID: 35800988
[TBL] [Abstract] [Full Text] [Related]
10. Long Noncoding RNA GAS5 in breast cancer: Epigenetic Mechanisms and Biological Functions.
Filippova EA; Fridman MV; Burdennyy AM; Loginov VI; Pronina IV; Lukina SS; Dmitriev AA; Braga EA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202777
[TBL] [Abstract] [Full Text] [Related]
11. The high protein expression of FOXO3, but not that of foxo1, is associated with markers of good prognosis.
Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
[TBL] [Abstract] [Full Text] [Related]
12. KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/foxo1 signaling.
Ye RY; Kuang XY; Zeng HJ; Shao N; Lin Y; Wang SM
J Clin Lab Anal; 2020 Aug; 34(8):e23315. PubMed ID: 32207860
[TBL] [Abstract] [Full Text] [Related]
13. Timeless-Stimulated miR-5188-foxo1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in breast cancer.
Zou Y; Lin X; Bu J; Lin Z; Chen Y; Qiu Y; Mo H; Tang Y; Fang W; Wu Z
Mol Ther; 2020 Jan; 28(1):313-327. PubMed ID: 31604679
[TBL] [Abstract] [Full Text] [Related]
14. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
[TBL] [Abstract] [Full Text] [Related]
15. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/foxo1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract] [Full Text] [Related]
16. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract] [Full Text] [Related]
17. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.
Harris IS; Blaser H; Moreno J; Treloar AE; Gorrini C; Sasaki M; Mason JM; Knobbe CB; Rufini A; Hallé M; Elia AJ; Wakeham A; Tremblay ML; Melino G; Done S; Mak TW
Oncogene; 2014 Feb; 33(8):1047-54. PubMed ID: 23435421
[TBL] [Abstract] [Full Text] [Related]
18. Cdc25A regulates matrix metalloprotease 1 through foxo1 and mediates metastasis of breast cancer cells.
Feng X; Wu Z; Wu Y; Hankey W; Prior TW; Li L; Ganju RK; Shen R; Zou X
Mol Cell Biol; 2011 Aug; 31(16):3457-71. PubMed ID: 21670150
[TBL] [Abstract] [Full Text] [Related]
19. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
Libura J; Drukala J; Majka M; Tomescu O; Navenot JM; Kucia M; Marquez L; Peiper SC; Barr FG; Janowska-Wieczorek A; Ratajczak MZ
Blood; 2002 Oct; 100(7):2597-606. PubMed ID: 12239174
[TBL] [Abstract] [Full Text] [Related]
